NasdaqCM:NUTXHealthcare
A Look At Nutex Health (NUTX) Valuation After Q1 2026 Earnings Surge And Expansion Plans
Nutex Health (NUTX) is back on investors’ radar after Q1 2026 results showed net income more than doubling year over year, stronger EPS, and continued hospital expansion plans supported by its existing arbitration driven model.
See our latest analysis for Nutex Health.
That earnings surprise and expansion pipeline have coincided with a sharp rebound in the shares, with a 1 day share price return of 17.1%, 7 day share price return of 28.9% and 30 day share price return of 41.8%. The 1 year...